Trince

Trince

Biotechnology Research

Ghent, Flemish Region 1,468 followers

Precision Transfections

About us

Trince is a spin-off company from Ghent University dedicated to advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo. The company's LumiPore transfection platform, which is covered by a portfolio of pending patents, combines laser exposure with photothermal nanoparticles to convert light energy into heat to transiently permeabilize the cellular plasma membrane. It can be used to deliver a wide variety of effector molecules (e.g. nucleic acids or proteins) into virtually any cell type, including hard-to-transfect cells such as immune cells for cell therapies. The technology not only makes it easier to bring genetic material into cells in high-throughput. It also ensures that this is done in a gentle manner, maximizing the therapeutic quality of the final cell product. www.trincebio.com

Website
http://www.trincebio.com
Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Ghent, Flemish Region
Type
Privately Held

Locations

  • Primary

    Ottergemsesteenweg-Zuid 731

    Ghent, Flemish Region 9500, BE

    Get directions

Employees at Trince

Updates

Similar pages

Funding

Trince 1 total round

Last Round

Seed

US$ 4.5M

See more info on crunchbase